Houston, TXNCT07874828Now EnrollingIRB Ready

Sarcoma,Soft Tissue Clinical Trial in Houston, TX

Access cutting-edge sarcoma,soft tissue treatment through this phase 2 clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.

Sponsored by M.D. Anderson Cancer Center

Quick Self-Assessment

See if you qualify for this Houston location

Preparing your pre-screening questions…

Expert Care in Houston

Access sarcoma,soft tissue specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related sarcoma,soft tissue treatment provided free

Apply for This Houston Location

Check if you qualify for this sarcoma,soft tissue clinical trial in Houston, TX

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Houston

    Convenient for TX residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Houston site if eligible
  4. 4Begin participation

About This Sarcoma,Soft Tissue Study in Houston

This is a prospective, single-arm, open-label feasibility trial conducted at the MD Anderson Sarcoma Center and Cardio-Oncology Clinic. The study will enroll young adults (18-39 years) with soft tissue or bone sarcoma who are overweight (BMI 25-29.9 kg/m² with ≥1 cardiovascular risk factor) or obese (BMI ≥30 kg/m²), have completed Dox-based chemotherapy (≥300 mg/m²) approximately three months prior to enrollment, and have preserved LVEF (≥50%) preenrollment.

Sponsor: M.D. Anderson Cancer Center

Who Can Participate

Inclusion Criteria

Age 18-39 years at enrollment
Histologically confirmed soft tissue or bone sarcoma with treatment that included Dox ≥ 300 mg/m².
Completed chemotherapy 3 months prior to enrollment; patient must be in remission at the time of enrollment with no planned systemic therapy, radiation therapy, or surgical oncologic intervention anticipated within the next 12 months.
Overweight (BMI 25-29.9 kg/m² with ≥1 cardiovascular risk factor) or obese (BMI ≥30 kg/m²) at the time of enrollment.
LVEF ≥ 50% at the time of enrollment with no symptoms of heart failure (NYHA class I-II).
ECOG performance status ≤2 (equivalent to Karnofsky ≥60%) at the time of enrollment.
Reproductive considerations:
Women of childbearing potential must agree to use adequate contraception (hormonal, barrier, IUD, or abstinence) beginning at enrollment and continuing for the duration of Tirz therapy.
Men must agree to use adequate contraception during study treatment and for 4 months after completion of Tirz.
Pregnancy testing will follow MD Anderson Policy CLN1114.
Ability to provide informed consent and willingness to comply with all study procedures, assessments, and follow-up requirements.

Exclusion Criteria

Preexisting diabetes mellitus requiring pharmacologic therapy.
Prior or current use of GLP-1 receptor agonists.
Ongoing active malignancy or ongoing systemic therapy for cancer treatment.
Patients who have not recovered from adverse events due to prior anti-cancer therapy (i.e., have residual toxicities \> Grade 1) with the exception of alopecia.
History of pancreatitis, medullary thyroid carcinoma, or MEN2.
Current participation in another interventional trial.
Pregnancy or breastfeeding.
Contraindication to GLP-1/GIP receptor agonists.
Psychiatric illness/social situations that would limit compliance with study requirements.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Houston?

Yes, this clinical trial (NCT07874828) has an active research site in Houston, TX that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Sarcoma,Soft Tissue Treatment Options in Houston, TX

If you're searching for sarcoma,soft tissue treatment options in Houston, TX, this clinical trial (NCT07874828) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Houston research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced sarcoma,soft tissue specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all sarcoma,soft tissue clinical trials near you to find additional studies recruiting in your area.

More Sarcoma Trials in Houston, TX

See all sarcoma clinical trials recruiting in Houston — not just this study.

Browse Sarcoma Trials in Houston →

Browse More Trials by Condition

Sarcoma TrialsAll Conditions →

Ready to Join in Houston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Houston, TX